Tanshinone IIA inhibits leukemia THP-1 cell growth by induction of apoptosis

Oncology Reports

Volumn 21, Issue 4, 2009, Pages 1075-1081

  Liu, Jia Jun ^a   Zhang, Yong ^b   Lin, Dong Jun ^a   Xiao, Ruo Zhi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Apoptosis; Leukemia; Tanshinone IIA

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; ANTILEUKEMIC AGENT; CASPASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; SURVIVIN; TANSHINONE IIA; ANTINEOPLASTIC AGENT; BIRC5 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; PHENANTHRENE DERIVATIVE; TANSHINONE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA; LEUKEMIA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; DRUG EFFECT; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; DNA FRAGMENTATION; HUMANS; LEUKEMIA; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROTUBULE-ASSOCIATED PROTEINS; PHENANTHRENES; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 67449083388     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000326     Document Type: Article

References (32)

1. Boon H and Wong J: Botanical medicine and cancer: a review of the safety and efficacy. Expert Opin Pharmacother 5: 2485-2501, 2004.
2. Zhou L, Zuo Z and Chow MS: Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45: 1345-1359, 2005.
3. Wang AM, Sha SH, Lesniak W and Schacht J: Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo. Antimicrob Agents Chemother 47: 1836-1841, 2003.
4. Yang LJ, Jeng CJ, Kung HN, Chang CC, Wang AG, Chau GY, Don MJ and Chau YP: Tanshinone IIA isolated from Salvia miltiorrhiza elicits the cell death of human endothelial cells. J Biomed Sci 12: 347-361, 2005.
5. Choi HS, Cho DI, Choi HK, Im SY, Ryu SY and Kim KM: Molecular mechanisms of inhibitory activities of tanshinones on lipopolysaccharide-induced nitric oxide generation in RAW 264.7 cells. Arch Pharm Res 27: 1233-1237, 2004.
6. Wang X, Wei Y, Yuan S, Liu G, Lu Y, Zhang J and Wang W: Potential anticancer activity of tanshinone IIA against human breast cancer. Int J Cancer 116: 799-807, 2005.
7. Yuan SL, Wei YQ, Wang XJ, Xiao F, Li SF and Zhang J: Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells. World J Gastroenterol 10: 2024-2028, 2004.
8. Rossi D and Gaidano G: Messengers of cell death: apoptotic signaling in health and disease. Haematologica 88: 212-218, 2003.
9. Tsuruo T, Naito M and Tomida A: Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci 94: 15-21, 2003.
10. Debatin KM: Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother 53: 153-197, 2004.
11. Yinjun L, Jie J and Weilai X: Homoharringtonine mediates myeloid cell apoptosis via upregulation of pro-apoptotic bax and inducing caspase-3-mediated cleavage of poly(ADP-ribose) polymerase (PARP). Am J Hematol 76: 199-204, 2004.
12. Treasure J: Herbal medicine and cancer: an introductory overview. Semin Oncol Nurs 21: 177-183, 2005.
13. Chan TY: Interaction between warfarin and danshen (Salvia miltiorrhiza). Ann Pharmacol 35: 501-504, 2001.
14. Yokozawa T and Chen CP: Role of Salvia miltiorrhiza radix extract and its compounds in enhancing nitric oxide expression. Phytomedicine 7: 55-61, 2000.
15. Zhou GY, Zhao BL, Hou JW, Ma GE and Xin WJ: Protective effects of sodium tanshinone IIA sulphonate against adriamycin-induced lipid peroxidation in mice hearts in vivo and in vitro. Pharmacol Res 40: 487-491,1999.
16. Mosaddik MA: In vitro cytotoxicity of tanshinones isolated from Salvia miltiorrhiza Bunge against P388 lymphocytic leukemia cells. Phytomedicine 10: 682-685, 2003.
17. Bailey LC, Lange BJ, Rheingold SR and Bunin NJ: Bone-marrow relapse in paediatric acute lymphoblastic leukaemia. Lancet Oncol 9: 873-883, 2008.
18. Cuvelier GD, Vitali AM, Ford JC and Dix DB: Multiple intracranial tumors in Philadelphia chromosome positive acute lymphoblastic leukemia: successful treatment following aggressive supportive care, early cranial radiation, high dose chemotherapy and imatinib. Pediatr Blood Cancer 51: 135-137, 2008.
19. Nicot C: Current views in HTLV-I-associated adult T-cell leukemia/ lymphoma. Am J Hematol 78: 232-239, 2005.
20. Levine B, Sinha S, Kroemer G and Manion MK: Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 4: 600-606, 2008.
21. Kim YH, Park C, Lee JO, Kim GY, Lee WH, Choi YH and Ryu CH: Induction of apoptosis by piceatannol in human leukemic U937 cells through down-regulation of Bcl-2 and activation of caspases. Oncol Rep 19: 961-967, 2008.
22. Sharpe JC, Arnoult D and Youle RJ: Control of mitochondrial permeability by Bcl-2 family members. Biochim Biophys Acta 1644: 107-113, 2004.
23. Kim R, Emi M and Tanabe K: Caspase-dependent and -independent cell death pathways after DNA damage (Review). Oncol Rep 14: 595-599, 2005.
24. Denault JB and Salvesen GS: Caspases: keys in the ignition of cell death. Chem Rev 102: 4489-4500, 2002.
25. Boatright KM and Salvesen GS: Caspase activation. Biochem Soc Symp 70: 233-242, 2003.
26. Qi SN, Yoshida A and Wang ZR: GP7 can induce apoptotic DNA fragmentation of human leukemia cells through caspase-3-dependent and -independent pathways. Int J Mol Med 13: 163-167, 2004.
27. Sercan HO, Pehlivan M, Simsek O, Ates H and Sercan Z: Induction of apoptosis increases expression of non-canonical WNT genes in myeloid leukemia cell lines. Oncol Rep 18: 1563-1569, 2007.
28. Mazumder S, Plesca D, Almasan A, Smolewski P, Darzynkiewicz Z and Robak T: Caspase-mediated cell death in hematological malignancies: theoretical considerations, methods of assessment, and clinical implications. Leuk Lymphoma 44: 1089-1104, 2003.
29. Morinaga S, Nakamura Y, Ishiwa N, Yoshikawa T, Noguchi Y, Yamamoto Y, Rino Y, Imada T, Takanashi Y, Akaike M, Sugimasa Y and Takemiya S: Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma. Oncol Rep 12: 1189-1194, 2004.
30. Nakao K, Hamasaki K, Ichikawa T, Arima K, Eguchi K and Ishii N: Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis. Oncol Rep 16: 389-392, 2006.
31. Wang J, Xu Z and Zhang M: Downregulation of survivin expression and elevation of caspase-3 activity involved in pitavastatin-induced HepG 2 cell apoptosis. Oncol Rep 18: 383-387, 2007.
32. Giannetti L, Consolo U, Magnoni C and Lo Muzio L: Apoptosis: escaping strategies in human skin cancer (Review). Oncol Rep 11: 401-405, 2004.